Cyber Monday saleUp to 70% OFF

Ligand Pharmaceuticals Incorporated

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

LGND chart

Key stats

Market capitalization
1.048BUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
71.82
Basic EPS (TTM)
0.96USD
Net income
−33.361MUSD
Revenue
196.245MUSD
Shares float
16.399M
Beta
1.46

About Ligand Pharmaceuticals Incorporated

Sector
Health Technology
CEO
Todd C. Davis
Headquarters
San Diego
Website
ligand.com
Employees (FY)
76
Founded
1987
ISIN
US53220K5048
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA.

Ideas

LGND is at the bottom of its range earnings reoprt 2/16/22they last reported sales were up 59% and profits were FAT because most of their revenues are from royalties so cost of sales is near zero. This looks like a reasonable spot to buy in front of earnings. www.earningswhispers.com
Long
by djh860
Stocks To Watch This WeekThe Bull Market is strong, the end of 2020 saw many growth names pull in or consolidate which gives a better reward to risk entry. Some of these charts still need to confirm their price action. This video is my watchlist. Most of these names are at or near all time highs or multi year highs. There a
Long
by Jtacher51
19
LGND. Consolidation and preparing for grow up.#LGND. The share has been in consolidation for a month now in the range of 108-118. EMA50 is preparing to pass EMA100 from bottom to top on the daily chart, which will be a strong enough signal to buy. If out of the range, the growth can be explosive, as Short Float is 58.36% Possible TP levels are
Long
by kovpups
LGND - Possible H&S short setup, Keeping on watch list. LGND seems breaking down from a (possible) H&S formation. It broke its neckline on strong volume. We are keeping it on our watch list as a potential short. Please check back for Trade updates. (Note: Trade update is little delayed here.)
Short
by AcornWealthCorp

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Financials

Performance
Revenue to profit conversion
Earnings
‪0‬

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.4Very Good
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.4Very Good
Learn more

See all brokers